Mahapatra DK, Bharti SK, Asati V. Anti-cancer chalcones: Structural and molecular target perspectives. Eur J Med Chem 2015; 98: 69-114.
Hardeland R. Melatonin in plants – diversity of levels and multiplicity of functions. Melatonin in plants – diversity of levels and multiplicity of functions. Front Plant Sci 2016; 7: 1-14.
Meng X, Li Y, Li S, et al. Dietary sources and bioactivities of melatonin. Nutr 2017; 9(4): 1-64.
Chuffa LGA, Reiter RJ, Lupi LA. Melatonin as a promising agent to treat ovarian Cancer: Molecular mechanisms. Carcinog 2017; 38: 945-52.
Chuffa LGA, Alves MS, Martinez M, et al. Apoptosis is triggered by melatonin in an in-vivo model of ovarian Carcinoma. Endocr Relat Cancer 2016; 23: 65-76.
Colombo J, Jardim PBV, Ferreira JPS, et al. Melatonin differentially modulates NF-KB expression in breast and liver cancer cells Anticancer Agents Med Chem 2018; 18: doi 10.2174/187152061
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65: 87-108.
Prakash O, Amit K, Pawan K, et al. anticancer potential of plants and natural products: A review. Am J Pharmacol Sci 2013; 1(6): 104-15.
Asati V, Mahapatra DK, Bharti SK. PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: structural and pharmacological perspectives. Eur J Med Chem 2016; 109: 314-41.
Donaldron MS. Nutrition and cancer - A review of the evidence for an anticancer diet. Nutr J 2004; 3: 1-21.
Riboli E, Norat T. Epidemiological evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr 2003; 78(3): 559-69.
Nichenametla SN, Taruscio TG, Barney DL, et al. A review of the effects and mechanisms of polyphenolics in cancer. Crit Rev Food Sci Nutr 2006; 46: 161-83.
Nirmala MJ, Samundeeswari A, Sankar PD. Natural plant resources in anti-cancer therapy-A review. Res Plant Biol 2011; 1(3): 1-14.
Channing J, Paller MD, Samuel R, et al. Challenges of conducting clinical trials of natural products to combat cancer. Clin Adv Hematol Oncol 2016; 14(6): 447-55.
Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 2012; 75(3): 311-35.
Amin AR, Kucuk O, Khuri FR, et al. Perspectives for cancer prevention with natural compounds. J Clin Oncol 2009; 27: 2712-25.
Ishikawa H, Saeki T, Otani T, et al. Aged garlic extract prevents a decline of NK cell number and activity in patients with advanced cancer. J Nutr 2006; 136: 816S-20S.
Tanaka Sh, Haruma K, Yoshihara M, et al. Aged garlic extract has potential suppressive effect on colorectal adenomas in humans. J Nutr 2006; 136: 821S-6S.
Natelson EA, Giovanella BC, Verschraegen CF, et al. Phase I clinical and pharmacological studies of 20-(S)-camptothecin and 20-(S)-9-nitrocamptothecin as anticancer agents. Ann N Y Acad Sci 1996; 803: 224-30.
Verschraegen CF, Gilbert BE, Loyer E, et al. Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(S)-camptothecin in patients with advanced pulmonary malignancies. Clin Cancer Res 2004; 10: 2319-26.
Shimada Y, Yoshino M, Wakui A, et al. Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer CPT-11 gastrointestinal cancer study group. J Clin Oncol 1993; 11: 909-13.
Cheng AL, Hsu CH, Lin JK, et al. Phase I clinical trial of curcumin, a chemo-preventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 2001; 21: 2895-900.
Dhillon N, Aggarwal BB, Newman RA, et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 2008; 14: 4491-9.
Bettuzzi S, Brausi M. Rizzi Federica, et al. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: A preliminary report from a one-year proof-of-principle study. Cancer Res 2006; 66: 1234-40.
Jian L, Xie LP, Lee AH, et al. Protective effect of green tea against prostate cancer: a case-control study in southeast China. Int J Cancer 2004; 108: 130-5.
Gao YT, McLaughlin JK, Blot WJ, et al. Reduced risk of esophageal cancer associated with green tea consumption. J Natl Cancer Inst 1994; 86: 855-8.
Ji BT, Chow WH, Hsing AW. Green tea consumption and the risk of pancreatic and colorectal cancers. Int J Cancer 1997; 27: 255-8.
Choan E, Segal R, Jonker D, et al. A prospective clinical trial of green tea for hormone refractory prostate cancer: An evaluation of the complementary/alternative therapy approach. Urol Oncol 2005; 23: 108-13.
Kim JH, Park CY. Effects of Sun Ginseng on subjective quality of life in cancer patients: A double-blind, placebo-controlled pilot trial. J Clin Pharm Ther 2006; 31: 331-4.
Suh SO, Kroh M, Kim NR, et al. Effects of red ginseng upon postoperative immunity and survival in patients with stage III gastric cancer. Am J Chin Med 2002; 30: 483-94.
Cragg GM, Newman DJ. Plants as a source of anti-cancer agents. J Ethnopharmacol 2005; 100: 72-9.
Okouneva T, Hill BT, Wilson L, et al. The effects of vinflunine, vinorelbine, and vinblastine on centromere dynamics. Mol Cancer Ther 2003; 2: 427-36.
Simoens C, Lardon F, Pauwels B, et al. Comparative study of the radiosensitising and cell cycle effects of vinflunine and vinorelbine In-vitro. BMC Cancer 2008; 8(65): 1-12.
Shoeb M, MacManus SM, Jaspars M, et al. Montamine, a unique dimeric indole alkaloid, from the seeds of Centaurea montana (Asteraceae), and its in-vitro cytotoxic activity against the CaCo2 colon cancer cells. Tetrahedron 2006; 62: 11172-7.
Lee KH, Xiao Z. Podophyllotoxins and analogs In Anticancer
Agents from Natural Products, edited by Cragg GM, Kingston
DGI, Newman DJ Brunner-Routledge Psychology Press Taylor &
Francis Group, Boca Raton; 2005; pp 71
Kingston DGI. The shape of things to come: Structural and synthetic studies of taxol and related compounds. Phytochemistry 2007; 68(14): 1844-54.
Hait WN, Rubin E, Alli E, et al. Tubulin targeting agents. Update Cancer Ther 2007; 2: 1-18.
Srivastava V, Negi AS, Kumar JK, et al. Plant-based anticancer molecules: A chemical and biological profile of some important leads. Bioorg Med Chem 2005; 13: 5892-8.
Creemers GJ, Bolis G, Gore M, et al. Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: Results of a large European phase II study. J Clin Oncol 1996; 14: 3056-61.
Fuchs C, Mitchell EP, Hoff PM. Irinotecan in the treatment of colorectal cancer. Cancer Treat Rev 2006; 32: 491-3.
Mineko I, Michio I, Ikuo M, et al. Growth inhibitory effect of a new camptothecin analog, DX-8951f, on various drug-resistant sublines including BCRP-mediated camptothecin derivative-resistant variants derived from the human lung cancer cell line PC- 6. Anticancer Drugs 2000; 11: 353-62.
Reichardt P, Nielsen OS, Bauer S, et al. Exatecan in pretreated adult patients with advanced soft tissue sarcoma: Results of a phase II – study of the EORTC soft tissue and bone sarcoma group. Eur J Cancer 2007; 43: 1017-22.
Zhang JA, Xuan T, Parmar M, et al. Development and characterization of a novel liposome-based formulation of SN-38. Int J Pharm 2004; 270: 93-107.
Cao Z, Kozielski A, Liu X, et al. Crystalline camptothecin-20(s)-opropionate hydrate: A novel anticancer agent with strong activity against 19 human tumor xenografts. Cancer Res 2009; 69: 4742-9.
Xie J, Ma T, Gu Y, et al. Berbamine derivatives: A novel class of compounds for anti-leukemia activity. Eur J Med Chem 2009; 44: 3293-8.
Xu R, Dong Q, Yu Y, et al. Berbamine: a novel inhibitor of bcr/abl fusion gene with potent anti-leukemia activity. Leuk Res 2006; 30: 17-23.
Wang F, Gao Y, Gao L, et al. Study on the electrochemical behavior of the anticancer herbal drug berberine and its analytical application. J Chin Chem Soc 2011; 58(4): 450-6.
Patil JB, Kim J, Jayaprakasha GK. Berberine induces apoptosis in breast cancer cells (MCF-7) through mitochondrial-dependent pathway. Eur J Pharmacol 2010; 645: 70-8.
Li Y, Li CJ, Yu D, et al. Potent induction of apoptosis by β- lapachone in human multiple myeloma cell lines and patient cells. Mol Med 2000; 6: 1008-15.
De Almeida ER. Preclinical and clinical studies of lapachol and betalapachone. Open Nat Prod J 2009; 2: 42-7.
Jeong SY, Park SJ, Yoon SM, et al. Systemic delivery and preclinical evaluation of Au nanoparticle containing β-lapachone for radiosensitization. J Control Release 2009; 139: 239-45.
Fulda S. Betulinic acid for cancer treatment and prevention. Int J Mol Sci 2008; 9: 1096-107.
Liaoo LL, Kupchan SM, Horwitz SB. Mode of action of the antitumor compound bruceantin, an inhibitor of protein synthesis. Mol Pharmacol 1976; 12: 167-76.
Dubey KK, Ray AR, Behera BK. Production of demethylated colchicines through microbial transformation and scale-up process development. Process Biochem 2008; 43: 251-7.
Thomson P, Naylor MA, Everett SA, et al. Synthesis and biological properties of bioreductively targeted nitrothienyl pro Ley drugs of combretastatin A-4. Mol Cancer Ther 2006; 5: 2886-94.
Ley CD, Horsmany MR, Kristjansen PEG. Early effects of combretastatin-A4 disodium phosphate on tumor perfusion and interstitial fluid pressure. Neoplasia 2007; 9: 108-12.
Molavi O, Ma Z, Mahmud A, Alshamsan A. Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors. Int J Pharm 2008; 347: 118-27.
Bernard SA, Olayinka OA. Search for a novel antioxidant, anti-inflammatory / analgesic or antiproliferative drug: cucurbitacins hold the ace. J Med Plants Res 2010; 4: 2821-6.
Sa G, Das T, Banerjee S, et al. Curcumin: From exotic spice to modern anticancer drug. Al Ameen J Med Sci 2010; 3: 21-7.
Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as “Curecumin”: from kitchen to clinic. Biochem Pharmacol 2008; 75: 787-9.
Surh YJ, Chun KS. Cancer chemopreventive effects of curcumin
In: Aggarwal BB, Surh YJ, Shishodia S, Eds The Molecular Targets
and Therapeutic Uses of Urcumin in Health and Disease London:
Springer; 2007 pp 149-72
Kim S, Hwang BY, Su BN, et al. Silvestrol, a potential anticancer rocaglate derivative from Aglaia foveolata, induces apoptosis in LNCaP cells through the mitochondrial/apoptosome pathway without activation of executioner caspase-3 or -7. Anticancer Res 2007; 27: 2175-83.
Lu CL, Li YM, Fu GQ, et al. Extraction optimisation of daphnoretin from root bark of Wikstroemia indica (L) CA and its antitumour activity tests. Food Chem 2011; 124: 1500-6.
Diogo CV, Felix L, Vilela S, et al. Mitochondrial toxicity of the phyotochemicals daphnetoxin and daphnoretin-relevance for possible anti-cancer application. Toxicol In Vitro 2009; 23: 772-9.
Kaufman PB, Duke JA, Brielmann H, et al. A comparative survey of leguminous plants as sources of the isoflavones, genistein and daidzein: implications for human nutrition and health. J Altern Compl Med Spring 1997; 3: 7-12.
Moon YJ, Wang X, Morris ME. Dietary flavonoids: Effects on xenobiotic and carcinogen metabolism. Toxicol In Vitro 2006; 20: 187-210.
Dixon RA, Ferreira D. Molecules of interest: Genistein. Phytochemistry 2002; 60: 205-11.
Kuo YC, Kuo PL, Hsu YL, et al. Ellipticine induces apoptosis through p53-dependent pathway in human hepatocellular carcinoma HepG2 cells. Life Sci 2006; 78: 2550-7.
Huang Z, Chen G, Shi P. Effects of emodin on the gene expression profiling of human breast carcinoma cells. Cancer Detect Prev 2009; 32: 286-91.
Mans DRA, Da Rocha AB, Schwartsmann G. Anti-cancer drug discovery and development in Brazil: Targeted plant collection as a rational strategy to acquire candidate anti-cancer compounds. Oncologist 2000; 5: 185-98.
Smith ME, Cimica V, Chinni S, et al. Rhabdoid tumor growth is inhibited by flavopiridol. Clin Cancer Res 2008; 14: 523-32.
Efferth T, Li PCH, Konkimalla VSB, et al. From traditional Chinese medicine to rational cancer therapy. Trends Mol Med 2007; 13: 353-61.
Nam S, Buettner R, Turkson J, et al. Indirubin derivatives inhibit Stat 3 signaling and induce apoptosis in human cancer cells. Proc Natl Acad Sci USA 2005; 102: 5998-6003.
Liu XM, Wung LG, Li HY, et al. Induction of differentiation and downregulation of c-myb gene expression in ML4 human myeloblastic leukemia cells by the clinically effective and leukemia agent meisoindigo. Biochem Pharmacol 1996; 51: 1545-51.
Hampson P, Wang K, Lord JM. Treatment of actinic keratoses, acute myeloid leukemia therapy, Treatment of basal cell carcinoma, Protein kinase C activator. Drugs Future 2005; 30: 1003.
Hazra B, Sarma MD, Sanyal U. Separation methods of quinonoid constituents of plants used in oriental traditional medicines. J Chromatogr B 2004; 812: 259-75.
Herst PM, Davis JE, Neeson P, et al. The anticancer drug, phenoxodiol, kills primary myeloid and lymphoid leukemic blasts and rapidly proliferating T cells. Haematologica 2009; 94: 928-34.
Pan L, Chai H, Kinghom AD. The continuing search for antitumor agents from higher plants. Phytochem Lett 2010; 3: 1-8.
Bardona S, Foussard V, Fournel S, et al. Monoterpenes inhibit proliferation of human colon cancer cells by modulating cell cycle-related protein expression. Cancer Lett 2002; 181: 187-94.
Yeruva L, Pierre KJ, Elegbede A, et al. Perillyl alcohol and perillic acid induced cell cycle arrest and apoptosis in non small cell lung cancer cells. Cancer Lett 2007; 257: 216-26.
Mi Q, Cui B, Silva GL, et al. Pervilleines A: A novel tropane alkaloid that reverses the multidrugresistance phenotype. Cancer Res 2001; 61: 4030-7.
Mi Q, Cui B, Silva GL, et al. Pervilleines B and C, new tropane alkaloid aromatic esters that reverse the multidrug-resistance in the hollow fiber assay. Cancer Lett 2002; 184: 13-20.
Mi Q, Cui B, Lantvit D, et al. Pervilleine F: A new tropane alkaloid aromatic ester that reverses multidrug resistance. Anticancer Res 2003; 23: 3607-15.
Deng F, Lu JJ, Liu HY, et al. Synthesis and antitumor activity of novel salvicine analogues. Chin Chem Lett 2011; 22: 25-8.
Shoeb M, Celik S, Jaspars M, et al. Isolation, structure elucidation and bioactivity of schischkiniin, a unique indole alkaloid from the seeds of Centaurea schischkinii. Tetrahedro 2005; 61: 9001-6.
Kinghorn D, de Blanco EJC, Chai HB, et al. Discovery of anticancer agents of diverse natural origin. Pure Appl Chem 2009; 81: 1051-63.
Kim JH, Xu C, Keum YS, et al. Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with beta-phenylethyl isothiocyanate and curcumin. Carcinogenesis 2006; 27: 475-82.
Liu Q. Triptolide and its expanding multiple pharmacological functions. Int Immunopharmacol 2011; 11: 377-83.
Ancuceanu RV, Istudor V. Pharmacologically active natural compounds for lung cancer. Altern Med Rev 2004; 9: 402-19.
Helong L, Liangxing T, Yongxin Z, et al. Improved bioavailability and antitumor effect of docetaxel by TPGS modified proniosomes: In Vitro and In Vivo evaluations. Sci Rep 2017; 43372: 1-11.
Abir KP, Dwaipayan C, Irene S, et al. New insights into therapeutic activity and anticancer properties of curcumin. J Exp Pharmacol 2017; 9: 31-45.